Table 3

The adverse events after intaking of sorafenib [the number of cases (%)]
CTCAE grade I II III
Symptom Number (%) Number (%) Number (%)
Hand-foot skin reaction 10 (22.2) 15 (33.3) 12 (26.7)
Rash 19 (42.2) 5 (11.1) 2 (4.44)
Diarrhea 17 (37.8) 4 (8.89) 1 (2.22)
Hair loss 17 (37.8) 2 (4.44) 2 (4.44)
Hypertension 15 (33.3) 7 (15.6) 3 (6.67)
Fatigue 22 (48.9) 3 (6.67) 0 (0)
Anorexia 12 (26.7) 2 (4.44) 0 (0)
Nausea 11 (24.4) 1 (2.22) 0 (0)
Depression 9 (20) 0 (0) 0 (0)
Muscle aches 14 (31.1) 0 (0) 0 (0)

Qu et al.

Qu et al. BMC Cancer 2012 12:263   doi:10.1186/1471-2407-12-263

Open Data